Taribavirin hydrochloride is an oral inhibitor of inosine monophosphate dehydrogenase (IMPDH) designed for liver-targeted delivery to treat hepatitis C virus (HCV). Its selective hepatic concentration aims to reduce systemic exposure and the risk of hemolytic anemia associated with similar antivirals. This mechanism supports its investigation in both in vitro virology studies and in vivo preclinical models of HCV infection.
Molekulargewicht:
279.68
CAS Nummer:
[40372-00-7]
Formel:
C8H14ClN5O4
Target-Kategorie:
Others,HBV,HCV Protease
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
